{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T23:06:03Z","timestamp":1768604763978,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS Graduate Research Assistance (GRA) Scheme"],"award-info":[{"award-number":["FRGS Graduate Research Assistance (GRA) Scheme"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2021\/SKK0\/USM\/02\/26"],"award-info":[{"award-number":["FRGS\/1\/2021\/SKK0\/USM\/02\/26"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11445-2","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:52:28Z","timestamp":1768564348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lutein reverses M2 macrophages polarization and exhibits antitumor effects on human triple-negative breast cancer cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Redzyque Ramza","family":"Ramli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siti Nur Hasyila","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Azlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma Abdullah","family":"Nurul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siti Norasikin Mohd","family":"Nafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-544X","authenticated-orcid":false,"given":"Agustine Nengsih","family":"Fauzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"11445_CR1","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.18632\/oncotarget.12284","volume":"8","author":"H Yao","year":"2017","unstructured":"Yao H, He G, Yan S et al (2017) Triple-negative breast cancer: is there a treatment on the horizon? Oncotarget 8:1913\u20131924. https:\/\/doi.org\/10.18632\/oncotarget.12284","journal-title":"Oncotarget"},{"key":"11445_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.575597","volume":"11","author":"KG Nguyen","year":"2020","unstructured":"Nguyen KG, Vrabel MR, Mantooth SM et al (2020) Localized interleukin-12 for cancer immunotherapy. Front Immunol 11:575597. https:\/\/doi.org\/10.3389\/fimmu.2020.575597","journal-title":"Front Immunol"},{"key":"11445_CR3","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.4049\/jimmunol.181.7.4461","volume":"181","author":"V Vila-del Sol","year":"2008","unstructured":"Vila-del Sol V, Punz\u00f3n C, Fresno M (2008) IFN-\u03b3-induced TNF-\u03b1 expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J Immunol 181:4461\u20134470. https:\/\/doi.org\/10.4049\/jimmunol.181.7.4461","journal-title":"J Immunol"},{"key":"11445_CR4","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF (2021) Macrophage polarization states in the tumor microenvironment. Int J Mol Sci 22:6995. https:\/\/doi.org\/10.3390\/ijms22136995","journal-title":"Int J Mol Sci"},{"key":"11445_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/20503121211069012","volume":"10","author":"B Mirlekar","year":"2022","unstructured":"Mirlekar B (2022) Tumor promoting roles of IL-10, TGF-\u03b2, IL-4, and IL-35: its implications in cancer immunotherapy. SAGE Open Med 10:205031212110690. https:\/\/doi.org\/10.1177\/20503121211069012","journal-title":"SAGE Open Med"},{"key":"11445_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302857","volume":"10","author":"M Hao","year":"2023","unstructured":"Hao M, Huang B, Wu R et al (2023) The interaction between macrophages and triple-negative breast cancer cells induces ROS-mediated interleukin 1\u03b1 expression to enhance tumorigenesis and metastasis. Adv Sci 10:e2302857. https:\/\/doi.org\/10.1002\/advs.202302857","journal-title":"Adv Sci"},{"key":"11445_CR7","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1111\/cas.15751","volume":"114","author":"Y Komohara","year":"2023","unstructured":"Komohara Y, Kurotaki D, Tsukamoto H et al (2023) Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes. Cancer Sci 114:2220\u20132229. https:\/\/doi.org\/10.1111\/cas.15751","journal-title":"Cancer Sci"},{"key":"11445_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0621-0","volume":"17","author":"S Sousa","year":"2015","unstructured":"Sousa S, Brion R, Lintunen M et al (2015) Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Res 17:101. https:\/\/doi.org\/10.1186\/s13058-015-0621-0","journal-title":"Breast Cancer Res"},{"key":"11445_CR9","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.2174\/13816128113199990591","volume":"20","author":"I Fabregat","year":"2014","unstructured":"Fabregat I, Fernando J, Mainez J, Sancho P (2014) Tgf-beta signaling in cancer treatment. Curr Pharm Des 20:2934\u20132947. https:\/\/doi.org\/10.2174\/13816128113199990591","journal-title":"Curr Pharm Des"},{"key":"11445_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1648","volume":"9","author":"C Chavey","year":"2007","unstructured":"Chavey C, Bibeau F, Gourgou-Bourgade S et al (2007) Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res 9:R15. https:\/\/doi.org\/10.1186\/bcr1648","journal-title":"Breast Cancer Res"},{"key":"11445_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.celrep.2016.09.008","volume":"17","author":"J Van den Bossche","year":"2016","unstructured":"Van den Bossche J, Baardman J, Otto NA et al (2016) Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep 17:684\u2013696. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.008","journal-title":"Cell Rep"},{"key":"11445_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/nu9020120","volume":"9","author":"B Eisenhauer","year":"2017","unstructured":"Eisenhauer B, Natoli S, Liew G, Flood V (2017) Lutein and zeaxanthin\u2014food sources, bioavailability and dietary variety in age-related macular degeneration protection. Nutrients 9:120. https:\/\/doi.org\/10.3390\/nu9020120","journal-title":"Nutrients"},{"key":"11445_CR13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/nu6020466","volume":"6","author":"J Fiedor","year":"2014","unstructured":"Fiedor J, Burda K (2014) Potential role of carotenoids as antioxidants in human health and disease. Nutrients 6:466\u2013488. https:\/\/doi.org\/10.3390\/nu6020466","journal-title":"Nutrients"},{"key":"11445_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.nut.2016.07.018","volume":"33","author":"G Bj\u00f8rklund","year":"2017","unstructured":"Bj\u00f8rklund G, Chirumbolo S (2017) Role of oxidative stress and antioxidants in daily nutrition and human health. Nutrition 33:311\u2013321. https:\/\/doi.org\/10.1016\/j.nut.2016.07.018","journal-title":"Nutrition"},{"key":"11445_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/molecules23040905","volume":"23","author":"X Gong","year":"2018","unstructured":"Gong X, Smith JR, Swanson HM, Rubin LP (2018) Carotenoid lutein selectively inhibits breast cancer cell growth and potentiates the effect of chemotherapeutic agents through ROS-mediated mechanisms. Mol J Synth Chem Nat Prod Chem 23:905. https:\/\/doi.org\/10.3390\/molecules23040905","journal-title":"Mol J Synth Chem Nat Prod Chem"},{"key":"11445_CR16","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1002\/jcp.29961","volume":"236","author":"YP Kavalappa","year":"2021","unstructured":"Kavalappa YP, Gopal SS, Ponesakki G (2021) Lutein inhibits breast cancer cell growth by suppressing antioxidant and cell survival signals and induces apoptosis. J Cell Physiol 236:1798\u20131809. https:\/\/doi.org\/10.1002\/jcp.29961","journal-title":"J Cell Physiol"},{"key":"11445_CR17","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.30.1_supplement.34.2","volume":"30","author":"HM Swanson","year":"2016","unstructured":"Swanson HM, Smith Jr. J. R., Gong X, Rubin LP (2016) Lutein, but not other carotenoids, selectively inhibits breast cancer cell growth through several molecular mechanisms. FASEB J 30:34.2\u201334.2. https:\/\/doi.org\/10.1096\/fasebj.30.1_supplement.34.2","journal-title":"FASEB J"},{"key":"11445_CR18","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1167\/iovs.05-1429","volume":"47","author":"X-H Jin","year":"2006","unstructured":"Jin X-H, Ohgami K, Shiratori K et al (2006) Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci 47:2562\u20132568. https:\/\/doi.org\/10.1167\/iovs.05-1429","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"11445_CR19","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2174\/1871520621666210427104804","volume":"22","author":"SNH Muhammad","year":"2022","unstructured":"Muhammad SNH, Yaacob NS, Safuwan NAM, Fauzi AN (2022) Antiglycolytic activities of strobilanthes crispus active fraction and its bioactivecomponents on triple-negative breast cancer cells in vitro. Anticancer Agents Med Chem 22:1363\u20131369. https:\/\/doi.org\/10.2174\/1871520621666210427104804","journal-title":"Anticancer Agents Med Chem"},{"key":"11445_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1177\/030089161109700518","volume":"97","author":"I Caras","year":"2011","unstructured":"Caras I, Tucureanu C, Lerescu L et al (2011) Influence of tumor cell culture supernatants on macrophage functional polarization: in vitro models of macrophage-tumor environment interaction. Tumori 97:647\u2013654. https:\/\/doi.org\/10.1177\/030089161109700518","journal-title":"Tumori"},{"key":"11445_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/ph16020153","volume":"16","author":"SNH Muhammad","year":"2023","unstructured":"Muhammad SNH, Safuwan NAM, Yaacob NS, Fauzi AN (2023) Regulatory mechanism on anti-glycolytic and anti-metastatic activities induced by strobilanthes crispus in breast cancer. Vitro Pharmaceuticals 16:153. https:\/\/doi.org\/10.3390\/ph16020153","journal-title":"Vitro Pharmaceuticals"},{"key":"11445_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/369609","volume":"2013","author":"BW Booth","year":"2013","unstructured":"Booth BW, Inskeep BD, Shah H et al (2013) Tannic acid preferentially targets estrogen receptor-positive breast cancer. Int J Breast Cancer 2013:369609. https:\/\/doi.org\/10.1155\/2013\/369609","journal-title":"Int J Breast Cancer"},{"key":"11445_CR23","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.biopha.2018.04.068","volume":"103","author":"B Choudhury","year":"2018","unstructured":"Choudhury B, Kandimalla R, Elancheran R et al (2018) Garcinia morella fruit, a promising source of antioxidant and anti-inflammatory agents induces breast cancer cell death via triggering apoptotic pathway. Biomed Pharmacother 103:562\u2013573. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.068","journal-title":"Biomed Pharmacother"},{"key":"11445_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/md16050160","volume":"16","author":"M Fan","year":"2018","unstructured":"Fan M, Nath AK, Tang Y et al (2018) Investigation of the anti-prostate cancer properties of marine-derived compounds. Mar Drugs 16:160. https:\/\/doi.org\/10.3390\/md16050160","journal-title":"Mar Drugs"},{"key":"11445_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5009\/gnl15208","volume":"10","author":"JH Kim","year":"2016","unstructured":"Kim JH, Park J-J, Lee BJ et al (2016) Astaxanthin inhibits proliferation of human gastric cancer cell lines by interrupting cell cycle progression. Gut Liver 10:369\u2013374. https:\/\/doi.org\/10.5009\/gnl15208","journal-title":"Gut Liver"},{"key":"11445_CR26","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.3390\/cimb45080434","volume":"45","author":"MM Moremane","year":"2023","unstructured":"Moremane MM, Abrahams B, Tiloke C (2023) Moringa oleifera: a review on the antiproliferative potential in breast cancer cells. Curr Issues Mol Biol 45:6880\u20136902. https:\/\/doi.org\/10.3390\/cimb45080434","journal-title":"Curr Issues Mol Biol"},{"key":"11445_CR27","unstructured":"Ngobili TA, Shah H, Park JP et al (2015) Remodeling of Tannic acid crosslinked collagen type I induces apoptosis in ER\u2009+\u2009Breast cancer cells. ANTICANCER Res"},{"key":"11445_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep29588","volume":"6","author":"J Tsuboki","year":"2016","unstructured":"Tsuboki J, Fujiwara Y, Horlad H et al (2016) Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophages. Sci Rep 6:29588. https:\/\/doi.org\/10.1038\/srep29588","journal-title":"Sci Rep"},{"key":"11445_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113522","volume":"267","author":"YS Baraya","year":"2021","unstructured":"Baraya YS, Yankuzo HM, Wong KK, Yaacob NS (2021) Strobilanthes crispus bioactive subfraction inhibits tumor progression and improves hematological and morphological parameters in mouse mammary carcinoma model. J Ethnopharmacol 267:113522. https:\/\/doi.org\/10.1016\/j.jep.2020.113522","journal-title":"J Ethnopharmacol"},{"key":"11445_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/cdn\/nzac049.004","volume":"6","author":"J Eom","year":"2022","unstructured":"Eom J, Kim H, Lim JW (2022) Lutein induces apoptosis of gastric cancer cells by producing reactive oxygen species via NADPH oxidase activation. Curr Dev Nutr 6:58. https:\/\/doi.org\/10.1093\/cdn\/nzac049.004","journal-title":"Curr Dev Nutr"},{"key":"11445_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.fct.2019.02.037","volume":"127","author":"E Gansukh","year":"2019","unstructured":"Gansukh E, Mya KK, Jung M et al (2019) Lutein derived from marigold (Tagetes erecta) petals triggers ROS generation and activates Bax and caspase-3 mediated apoptosis of human cervical carcinoma (HeLa) cells. Food Chem Toxicol 127:11\u201318. https:\/\/doi.org\/10.1016\/j.fct.2019.02.037","journal-title":"Food Chem Toxicol"},{"key":"11445_CR32","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.fct.2010.04.011","volume":"48","author":"R Lakshminarayana","year":"2010","unstructured":"Lakshminarayana R, Sathish UV, Dharmesh SM, Baskaran V (2010) Antioxidant and cytotoxic effect of oxidized lutein in human cervical carcinoma cells (HeLa). Food Chem Toxicol 48:1811\u20131816. https:\/\/doi.org\/10.1016\/j.fct.2010.04.011","journal-title":"Food Chem Toxicol"},{"key":"11445_CR33","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4332","author":"Y Li","year":"2018","unstructured":"Li Y, Zhang Y, Liu X et al (2018) Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2018.4332","journal-title":"Int J Oncol"},{"key":"11445_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.30476\/mejc","volume":"12","author":"WM Omar","year":"2021","unstructured":"Omar WM, Ahmed AE, Raslan M et al (2021) Effect of Lutein-Rich extract on human cancer cells. Middle East J Cancer 12:147\u2013150. https:\/\/doi.org\/10.30476\/mejc","journal-title":"Middle East J Cancer"},{"key":"11445_CR35","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.11847\/zgggws1120135","volume":"34","author":"X Ye","year":"2018","unstructured":"Ye X, Zhao L, Jin D (2018) Inhibitory effect of lutein on proliferation of human prostate cancer PC-3 M cells. Chin J Public Health 34:1642\u20131645. https:\/\/doi.org\/10.11847\/zgggws1120135","journal-title":"Chin J Public Health"},{"key":"11445_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin Y, Xu J, Lan H (2019) Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol OncolJ Hematol Oncol 12:76. https:\/\/doi.org\/10.1186\/s13045-019-0760-3","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"11445_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01208-y","volume":"21","author":"X Ji","year":"2023","unstructured":"Ji X, Huang X, Li C et al (2023) Effect of tumor-associated macrophages on the pyroptosis of breast cancer tumor cells. Cell Commun Signal 21:197. https:\/\/doi.org\/10.1186\/s12964-023-01208-y","journal-title":"Cell Commun Signal"},{"key":"11445_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax6337","volume":"12","author":"JM Jaynes","year":"2020","unstructured":"Jaynes JM, Sable R, Ronzetti M et al (2020) Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. Sci Transl Med 12:eaax6337. https:\/\/doi.org\/10.1126\/scitranslmed.aax6337","journal-title":"Sci Transl Med"},{"key":"11445_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/npjbcancer.2015.25","volume":"2","author":"CB Williams","year":"2016","unstructured":"Williams CB, Yeh ES, Soloff AC (2016) Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. NPJ Breast Cancer 2:15025. https:\/\/doi.org\/10.1038\/npjbcancer.2015.25","journal-title":"NPJ Breast Cancer"},{"key":"11445_CR40","doi-asserted-by":"publisher","unstructured":"Yuan Z-Y, Luo R-Z, Peng R-J et al (2014) High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis. OncoTargets Ther 1475. https:\/\/doi.org\/10.2147\/OTT.S61838","DOI":"10.2147\/OTT.S61838"},{"key":"11445_CR41","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1042\/CS20220531","volume":"137","author":"Z Strizova","year":"2023","unstructured":"Strizova Z, Benesova I, Bartolini R et al (2023) M1\/M2 macrophages and their overlaps \u2013 myth or reality? Clin Sci 137:1067\u20131093. https:\/\/doi.org\/10.1042\/CS20220531","journal-title":"Clin Sci"},{"key":"11445_CR42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/cancers13020167","volume":"13","author":"B Mirlekar","year":"2021","unstructured":"Mirlekar B, Pylayeva-Gupta Y (2021) IL-12 family cytokines in cancer and immunotherapy. Cancers 13:167. https:\/\/doi.org\/10.3390\/cancers13020167","journal-title":"Cancers"},{"key":"11445_CR43","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/annonc\/mds333","volume":"24","author":"EM de Kruijf","year":"2013","unstructured":"de Kruijf EM, Dekker TJA, Hawinkels LJAC et al (2013) The prognostic role of TGF-\u03b2 signaling pathway in breast cancer patients. Ann Oncol 24:384\u2013390. https:\/\/doi.org\/10.1093\/annonc\/mds333","journal-title":"Ann Oncol"},{"key":"11445_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/bcr44","volume":"2","author":"N Dumont","year":"2000","unstructured":"Dumont N, Arteaga CL (2000) Transforming growth factor-beta and breast cancer: tumor promoting effects of transforming growth factor-\u03b2. Breast Cancer Res 2:125. https:\/\/doi.org\/10.1186\/bcr44","journal-title":"Breast Cancer Res"},{"key":"11445_CR45","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nrc3627","volume":"13","author":"HL Goel","year":"2013","unstructured":"Goel HL, Mercurio AM (2013) VEGF targets the tumour cell. Nat Rev Cancer 13:871\u2013882. https:\/\/doi.org\/10.1038\/nrc3627","journal-title":"Nat Rev Cancer"},{"key":"11445_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27010137","volume":"27","author":"Z-J Han","year":"2021","unstructured":"Han Z-J, Li Y-B, Yang L-X et al (2021) Roles of the CXCL8-CXCR1\/2 axis in the tumor microenvironment and immunotherapy. Molecules 27:137. https:\/\/doi.org\/10.3390\/molecules27010137","journal-title":"Molecules"},{"key":"11445_CR47","unstructured":"Jang SY, Kim A, Kim JK et al (2014) Metformin inhibits tumor cell migration via Down-regulation of MMP9 in Tamoxifen-resistant breast cancer cells. ANTICANCER Res"},{"key":"11445_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.722916","author":"J Jin","year":"2021","unstructured":"Jin J, Lin J, Xu A et al (2021) CCL2: an important mediator between tumor cells and host cells in tumor microenvironment. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.722916","journal-title":"Front Oncol"},{"key":"11445_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223698","volume":"11","author":"M Ra\u0161kov\u00e1","year":"2022","unstructured":"Ra\u0161kov\u00e1 M, Lacina L, Kej\u00edk Z et al (2022) The role of IL-6 in cancer cell invasiveness and metastasis\u2014overview and therapeutic opportunities. Cells 11:3698. https:\/\/doi.org\/10.3390\/cells11223698","journal-title":"Cells"},{"key":"11445_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207619","volume":"21","author":"J Korbecki","year":"2020","unstructured":"Korbecki J, Grochans S, Gutowska I et al (2020) CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 ligands. Int J Mol Sci 21:7619. https:\/\/doi.org\/10.3390\/ijms21207619","journal-title":"Int J Mol Sci"},{"key":"11445_CR51","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A et al (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14:399\u2013416. https:\/\/doi.org\/10.1038\/nrclinonc.2016.217","journal-title":"Nat Rev Clin Oncol"},{"key":"11445_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK et al (2014) Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines. Immunity 41:14\u201320. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.008","journal-title":"Immunity"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11445-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11445-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11445-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:52:32Z","timestamp":1768564352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11445-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11445"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11445-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Human Research Ethics Committee of Universiti Sains Malaysia (USM\/JEPeM\/21100704).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"was obtained from all participants","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"295"}}